Prospective, Randomized Study Evaluating The Efficacy of Chlorhexidine Gluconate Impregnated No-Rinse Cloths.

NCT ID: NCT02469311

Last Updated: 2018-03-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

539 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subjects in the study were randomized to a treatment group using Chlorhexidine cloths or a standard-of-care group who only had a bath with antibacterial soap and water. Both groups received standard infection control practices during admission.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Between March 2012 and November 2012, patients scheduled for total hip arthroplasty (THA) or total knee arthroplasty (TKA) were randomized (539 patients; 554 arthroplasties) at the time of their preoperative clinic visit. Patients in the chlorhexidine protocol group (275 arthroplasties) applied 2% chlorhexidine gluconate-impregnated cloths to their skin the night before and the morning of surgical admission. Patients in the standard of care group (279 arthroplasties) took a bath with soap and water the night before surgical admission. Both groups were subject to standard infection control practices during admission. The primary outcome was periprosthetic infection incidence within one year of surgery, and secondary outcomes included the potential influence of risk factors for periprosthetic infection and incidence of adverse events.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Primary Control TKA

Patients undergoing a first or primary total knee arthroplasty will be randomized to the intervention of Standard of care bathing with antibacterial soap and water.

Group Type SHAM_COMPARATOR

Standard of care bathing with antibacterial soap and water

Intervention Type OTHER

Patients had standard pre-operative bathing with antibacterial soap and water the night before surgery.

Primary Treatment TKA

Patients undergoing a first or primary total knee arthroplasty will be randomized to the intervention of chlorhexidine impregnated cloths.

Group Type ACTIVE_COMPARATOR

chlorhexidine impregnated cloths

Intervention Type OTHER

Pre-operative use of Chlorhexidine cloths night before and morning of surgery

Revision Treatment TKA

Patients undergoing a second or subsequent or a revision total knee arthroplasty will be randomized to the intervention of a chlorhexidine impregnated cloths.

Group Type ACTIVE_COMPARATOR

chlorhexidine impregnated cloths

Intervention Type OTHER

Pre-operative use of Chlorhexidine cloths night before and morning of surgery

Revision Control TKA

Patients undergoing a second or revision total knee arthroplasty will be randomized to the intervention of Standard of care bathing with antibacterial soap and water.

Group Type SHAM_COMPARATOR

Standard of care bathing with antibacterial soap and water

Intervention Type OTHER

Patients had standard pre-operative bathing with antibacterial soap and water the night before surgery.

Primary Control THA

Patients undergoing a first or primary total hip arthroplasty will be randomized to the intervention of Standard of care bathing with antibacterial soap and water.

Group Type SHAM_COMPARATOR

Standard of care bathing with antibacterial soap and water

Intervention Type OTHER

Patients had standard pre-operative bathing with antibacterial soap and water the night before surgery.

Primary Treatment THA

Patients undergoing a first or primary total hip arthroplasty will be randomized to the intervention of chlorhexidine impregnated cloths.

Group Type ACTIVE_COMPARATOR

chlorhexidine impregnated cloths

Intervention Type OTHER

Pre-operative use of Chlorhexidine cloths night before and morning of surgery

Revision Control THA

Patients undergoing a second or revision total hip arthroplasty will be randomized to the intervention of Standard of care bathing with antibacterial soap and water.

Group Type SHAM_COMPARATOR

Standard of care bathing with antibacterial soap and water

Intervention Type OTHER

Patients had standard pre-operative bathing with antibacterial soap and water the night before surgery.

Revision Treatment THA

Patients undergoing a second or subsequent or a revision total knee arthroplasty will be randomized to the intervention of chlorhexidine impregnated cloths.

Group Type ACTIVE_COMPARATOR

chlorhexidine impregnated cloths

Intervention Type OTHER

Pre-operative use of Chlorhexidine cloths night before and morning of surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

chlorhexidine impregnated cloths

Pre-operative use of Chlorhexidine cloths night before and morning of surgery

Intervention Type OTHER

Standard of care bathing with antibacterial soap and water

Patients had standard pre-operative bathing with antibacterial soap and water the night before surgery.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Joint replacement surgery for any reason
* 18 years or older

Exclusion Criteria

* unable to comply with study requirements
* were pregnant
* were under the age of 18 years
* medical history of immunosuppression or systemic disease e.g. human immunodeficiency virus, status-post organ transplantation
* received greater than 10 milligrams of prednisone equivalent for more than 10 days within 90 days prior to enrollment;
* chronic hepatitis B or C infection
* had an infection in or around the joint requiring surgery.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LifeBridge Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael A Mont, MD

Role: PRINCIPAL_INVESTIGATOR

Director, Rubin Instituted for Advanced Orthopedics and Joint Preservation and Replacement

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LifeBridgeH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.